XTENT Inc (XTNT)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
CEO:
Sean E. Browne
Employees:
120
664 CRUISER LANE, BELGRADE, MT 59714
406-388-0480

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment. The company also provides 3Demin, a family of allografts that maximizes osteoconductivity and osteoinductive potential of human bone.

Data derived from most recent annual or quarterly report
Market Cap 14.435 Million Shares Outstanding23.283 Million Avg 30-day Volume 58.431 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.02
Price to Revenue0.8103 Debt to Equity0.5632 EBITDA-5.289 Million
Price to Book Value1.6117 Operating Margin-11.5912 Enterprise Value44.363 Million
Current Ratio3.571 EPS Growth-1.833 Quick Ratio2.117
1 Yr BETA 0.5501 52-week High/Low 0.0 / Profit Margin-14.3082
Operating Cash Flow Growth-183.4919 Altman Z-Score-3.8932 Free Cash Flow to Firm -2.455 Million

Are you looking for these stocks instead?

View SEC Filings from XTNT instead.

View recent insider trading info

Funds Holding XTNT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding XTNT

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MARCO PHILIPPE H VP-QA, CLINICAL & REG. AFFAIRS

  • Officer
69,800 2008-10-01 0

CASCIARO GREGORY D PRESIDENT AND CEO

  • Officer
  • Director
0 2008-08-13 0

ANDREAS BERNARD H VP-INNOVATION AND CONCEPT DEV

  • Officer
No longer subject to file 2008-08-13 0

CAMPBELL RANDOLPH E CHIEF TECHNICAL OFFICER

  • Officer
0 2008-08-13 0

KAHLENBERG TIMOTHY D CHIEF FINANCIAL OFFICER

  • Officer
0 2008-08-13 0

HODKINSON ANNE-MARIE VP HUMAN RESOURCES

  • Officer
0 2008-08-13 0

WALSH BRIAN J

  • FORMER VP-SALES & MARKETING
No longer subject to file 2008-07-18 0

TAYLOR ARTHUR T

  • Director
0 2008-06-18 0

FLAHERTY ROBERT E

  • Director
0 2008-06-18 0

SPLIT ROCK PARTNERS LLC

SPVC VI, LLC

  • 10% Owner
2,615,135 2008-06-18 0

EAGLE MICHAEL L

  • Director
0 2008-06-18 0

UNKART EDWARD W

  • Director
0 2008-06-18 0

CARUSI MICHAEL A

  • Director
0 2008-06-18 0

WILL ALLAN R

  • Director
  • 10% Owner
2,775,291 2008-06-18 0

PLAIN HENRY A JR

  • Director
0 2008-06-18 0

SMITH CHRISTOPHER M

  • Director
0 2008-06-18 0

GRAINGER JEFFRY J VP-CORP AFFAIRS & GEN. COUNSEL

  • Officer
109,500 2008-04-02 0

BELLAS ROBERT C JR

  • Director
10,000 2007-06-20 0

TRAVELERS COMPANIES, INC.

ST PAUL FIRE & MARINE INSURANCE CO

  • 10% Owner
  • JOINT FILER
0 2007-05-09 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

No recent transactions

*** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

Elevate your investments